Pharmaceutical

UK bans xylazine and 21 other substances to fight drug ...

The UK government has taken a step towards banning xylazine and 21 other substan...

ArsenalBio secures $325m to develop cell therapy progra...

ArsenalBio has secured $325m in a Series C financing round to propel its program...

Lilly and EVA Pharma to expand baricitinib access in Af...

Eli Lilly and EVA Pharma have formed a partnership to increase the availability ...

ESC 2024: Insights into RNA as therapeutic target and tool

A panel of researchers gave presentations on the clinical evidence for the role ...

ESC 2024: New PACMAN-AMI trial analysis sheds insights ...

The subanalyses recontextualised data from the PACMAN-AMI trial on the therapeut...

Lilly partners with Haya for lncRNA obesity target deal...

Haya could secure up to $1bn after hitting preclinical, clinical, and commercial...

Moderna mpox mRNA vaccine shows early promise in monkey...

Moderna is currently running a Phase I/II trial of the mRNA mpox vaccine mRNA-17...

eGenesis scoops $191m for genetically modified pig kidn...

eGenesis conducted the first-in-human porcine kidney transplant earlier this yea...

Skyline wins orphan drug designation for retinitis pigm...

There are currently no approved treatments that can halt or reverse photorecepto...

UK NHS launches vaccine programme for RSV

The UK NHS has commenced its first-ever vaccination programme for RSV vaccine, t...

Simcere Zaiming and TargetRx agree TGRX-326 commercial ...

Simcere Zaiming has entered a collaboration deal with Shenzhen TargetRx to bring...

Why the Importer of Record (IoR) is vital in the clinic...

In clinical supplies, the Importer of Record (IoR) provides a critical service i...

Syntekabio and Enamine partner for AI-based drug develo...

Syntekabio has entered a partnership with Enamine for supply, synthesis of compo...

ESC 2024: Beta blocker treatment paradigm shifts for my...

New data provides more evidence on choosing the ideal approach for prescription ...

UAE MoHAP and Novo Nordisk partner for obesity management

The UAE has partnered with Novo Nordisk Pharma Gulf to develop a national scient...

FDA grants fast track status to Innovent’s IBI363 for m...

The US Food and Drug Administration (FDA) has granted fast track designation to ...